These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8220114)

  • 21. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H; Davies S; McGlave P
    Clin Transpl; 1994; ():283-93. PubMed ID: 7547549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes.
    Slavin S; Ackerstein A; Morecki S; Gelfand Y; Cividalli G
    Bone Marrow Transplant; 2001 Oct; 28(8):795-8. PubMed ID: 11781634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation.
    Steegmann JL; Casado LF; Tomás JF; Sanz-Rodríguez C; Granados E; de la Cámara R; Alegre A; Vázquez L; Ferro MT; Figuera A; Arranz R; Fernández-Rañada JM
    Bone Marrow Transplant; 1999 Mar; 23(5):483-8. PubMed ID: 10100563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
    Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
    Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
    Mehta J; Powles R; Kulkarni S; Treleaven J; Singhal S
    Bone Marrow Transplant; 1997 Jul; 20(2):129-35. PubMed ID: 9244416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
    Hehlmann R; Hochhaus A; Kolb HJ; Hasford J; Gratwohl A; Heimpel H; Siegert W; Finke J; Ehninger G; Holler E; Berger U; Pfirrmann M; Muth A; Zander A; Fauser AA; Heyll A; Nerl C; Hossfeld DK; Löffler H; Pralle H; Queisser W; Tobler A
    Blood; 1999 Dec; 94(11):3668-77. PubMed ID: 10572078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
    Alimena G; Meloni G; de Cuia MR; Rondinelli MB; Lo Coco F; Montefusco E; Mancini M; Pinto R; Nanni M; Cedrone M
    Leuk Lymphoma; 1993; 11 Suppl 1():281-91. PubMed ID: 7902746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report.
    Lönnqvist B; Brune M; Ljungman P
    Bone Marrow Transplant; 1996 Jul; 18(1):241-2. PubMed ID: 8832027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of treatment of children with chronic myelogenous leukaemia (CML) obtained by the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Chybicka A; Kałwak K; Bogusławska-Jaworska J; Turkiewicz D; Armata J; Balcerska A; Bubała H; Boruczkowski D; Cwiklińska M; Hicke A; Kaczmarek-Kanold M; Kolecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Staszak-Kowalska R; Tomaszewska R; Wiśniewska-Slusarz H; Wachowiak J; Wysocki M;
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):49-55. PubMed ID: 12021462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of chronic myeloid leukaemia--a case history.
    Sureda A; Hernández-Bronchud M
    Ann Oncol; 1997 Jan; 8(1):91-6. PubMed ID: 9093713
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.
    Boiron JM; Cony-Makhoul P; Mahon FX; Pigneux A; Puntous M; Reiffers J
    Blood Rev; 1994 Dec; 8(4):234-40. PubMed ID: 7888830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful stimulation of autologous bone marrow recovery by GM-CSF and IL-3 after an unrelated donor BMT for juvenile CML complicated by graft failure.
    Suttorp M; Schmitz N; Prange E; Ganser A; Löffler H; Schaub J
    Bone Marrow Transplant; 1991; 7 Suppl 2():84. PubMed ID: 1878734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties.
    Kolb HJ
    Vox Sang; 1998; 74 Suppl 2():321-9. PubMed ID: 9704463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.
    Beelen DW; Graeven U; Elmaagacli AH; Niederle N; Kloke O; Opalka B; Schaefer UW
    Blood; 1995 May; 85(10):2981-90. PubMed ID: 7742558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
    Nese M; de Bellis R; Urtiarte R; Di Landro J
    Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival.
    Hehlmann R; Heimpel H
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():161-7. PubMed ID: 8951787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
    Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
    Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.